Development of a 5-FU Modified miR-129 Mimic as a Therapeutic for Non-Small Cell Lung Cancer
G.-R. Hwang, J. G. Yuen, A. Fesler, H. Farley, J. D. Haley, J. Ju
This study develops a 5-FU modified miR-129 mimic that inhibits NSCLC proliferation, induces apoptosis, overcomes drug resistance, and extends survival in vivo without toxicity.
bioRxiv · Sep 16, 2022Cancer Biology